#BrazilSFE #Wellbeing #Career #Balance #Flexibility #PharmaceuticalIndustry #YoungPeopleintheMarket #Purpose #Sustainability #Technology #Time
The Pharmaceutical Industry is very demanding, but young people between 24 and 36 years old do not need to sacrifice their lives for their career.
1. Compliance Monitoring in the Pharmaceutical Industry: The AI Revolution | AiCure
2. The Future of Work in the Pharmaceutical Industry: What Young People Need to Know
3. How to Build a Successful Career in the Pharmaceutical Industry in 10 Years
4. How to Balance Life and Career in the Pharmaceutical Industry Before Age 36
5. Who Is the Digital Opinion Leader Crew? Mapping Your HCP Fan Base.png)
6. Important Tips | How to Improve Marketing Performance - Market and Customer Insights
Balancing both is possible and essential. This article offers strategies for success without burnout.
Salary Survey by Latin American Country (2020-2024)Data compiled from sources such as INEGI (Mexico), FATFA (Argentina), DANE (Colombia), MTESS (Paraguay), and platforms such as Glassdoor/Talent.com. By company: Limited to publicly available examples; focus on mid-level positions (pharmaceutical chemist/analyst). Trends: Adjusted for inflation where possible.
This survey focuses on pharmaceutical industry salaries in the requested countries ( Mexico , Argentina , Bolivia , Ecuador , Colombia , Chile , Peru , Venezuela , Uruguay , and Paraguay ) between 2020 and 2024, by company when available. Data are based on official sources, industry reports, and job boards, but vary by position, experience, and location.
MexicoThe industry grew 6-7% annually, generating 75,000 direct jobs. Average salaries for pharmaceutical chemists: MXN 12,000-24,000/month (US$600-1,200). Multinationals like Pfizer pay +20%.
Balance : Companies like Baxter offer flexibility; avoid overloading production.
ArgentinaHigh inflation (50-100%/year) erodes real wages. Average for a pharmacist: ARS 180,000-919,000/month (US$200-1,000, adjusted). FATFA regulates pay scales.
Balance : Annual parities help; opt for remote ones in Buenos Aires.
BoliviaData is scarce; the sector is small, with a focus on imports. Average pharmaceutical revenue: BOB 3,000-5,000/month (US$430-720). Growth is +10% annually.
Balance : Emerging sector; less pressure, but unstable.
EcuadorGrowth +15% post-pandemic. Average: USD 800-1,500/month. Sector minimum wage ~USD 460.
Balance : Flexible regulations; good for young professionals.
ColombiaStrong sector (4th in Latin America); 6% growth/year. Average pharmaceutical chemist: COP 3-6M/month (US$750-1,500). LHH: Scales by company size.
Balance : Labor laws protect; health sector 5.1% of GDP.
ChileGrowth 4-6%/year; 0.73% GDP. Chemical average: CLP 1.2-2.2M/month (US$1,300-2,400).
Balance : Low seasonality; focus on innovation.
PeruGrowth 4%; 93% in Lima. Average: PEN 2,000-5,000/month (US$530-1,320).
Balance : Opportunities in R&D; avoid overload in production.
VenezuelaEconomic crisis; 14.6% growth in 2024, but low wages (~US$180 average). High inflation.
Equilibrium : Unstable; common migration to equilibrium.
UruguayStable; farm subgroup with annual adjustments (e.g., +5.3% 2024). Average: UYU 40,000-60,000/month (US$1,000-1,500).
Balance : Low inequality; good for families.
ParaguayGrowth 60% (2019-2024); 45,000 jobs. Minimum wages ~Gs. 2.8M/month (US$370); average pharmacist Gs. 4-7M (US$530-930).
Balance : Fast growth; focus on maquila.
This survey focuses on pharmaceutical industry salaries in the requested countries ( Mexico , Argentina , Bolivia , Ecuador , Colombia , Chile , Peru , Venezuela , Uruguay , and Paraguay ) between 2020 and 2024, by company when available. Data are based on official sources, industry reports, and job boards, but vary by position, experience, and location.
Note: Company-specific data is limited due to confidentiality; where possible, we highlight examples of large players such as Pfizer, GSK, or local companies such as Inkafarma. Salaries are approximate in local currency (monthly, gross) and converted to USD (average rate 2024: 1 USD ≈ 5,500 ARS, 18 MXN, 7,000 PYG, etc.). Inflation affects historical values, especially in Argentina and Venezuela.
Again | Average Salary (MXN/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 10.000-18.000 | Pfizer: ~15,000; Local (Generic): 10,000 | COVID Impact; +5% growth. |
2021 | 11.000-20.000 | Baxter: ~18.000; IFA Celtics: 12.000 | IED US$981M; 52.400 empregos. |
2022 | 12.000-22.000 | MICROIN: ~16,000; Canifarma branches: 13,000 | Sectoral GDP +1.13% (2016-19 base). |
2023 | 13.000-24.000 | GSK: ~20.000; NoyMed: 15.000 | +0.93% GDP Q1; 2.17M healthcare jobs. |
2024 | 14.000-26.000 | Johnson & Johnson: ~22,000; Locations: 16,000 | Projection +6.7%; farm average MXN 18,000 (US$900). |
ArgentinaHigh inflation (50-100%/year) erodes real wages. Average for a pharmacist: ARS 180,000-919,000/month (US$200-1,000, adjusted). FATFA regulates pay scales.
Again | Average Salary (ARS/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 50.000-100.000 | Roemmers: ~80.000; Locais: 60.000 | Parity +91%; pandemic impact. |
2021 | 80.000-150.000 | Bagó: ~120,000; Farmacity: 100,000 | +35% production; MSL: ARS 40,000-42,000 (adjusted). |
2022 | 120.000-300.000 | Pfizer: ~250,000; Area: 180,000 | SAFYB scale: +3%; inflation 95%. |
2023 | 200.000-600.000 | GSK: ~400.000; Multilabs: 300.000 | +91% SAFYB; base ARS 750,000 (US$800). |
2024 | 300.000-1.000.000 | Inkafarma (expansion): ~600,000; Director: ARS 2,131,000 (US$2,200) | FATFA scale: +13%; average ARS 919,000 (US$950). |
BoliviaData is scarce; the sector is small, with a focus on imports. Average pharmaceutical revenue: BOB 3,000-5,000/month (US$430-720). Growth is +10% annually.
Again | Average Salary (BOB/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020-2022 | 2.500-4.000 | Locations (e.g., Lifapharm): ~3,000 | Production +20%; little data per company. |
2023 | 3.000-4.500 | Importers: 3,500 | US$500M market; 5% health GDP. |
2024 | 3.200-5.000 | Multinationals: ~4,000 | Projection +15%; high qualification 48% jobs. |
EcuadorGrowth +15% post-pandemic. Average: USD 800-1,500/month. Sector minimum wage ~USD 460.
Again | Average Salary (USD/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 700-1.200 | Stiefel: ~1,000; Locals: 800 | Hiring +10%; pandemic impact. |
2021 | 750-1.300 | Pfizer: ~1.200 | Sales +42%; 39% local production. |
2022 | 800-1.400 | GSK: ~1.300 | Mercado USD 2.165M. |
2023 | 850-1.500 | Importers: 1,000 | +51% imports. |
2024 | 900-1.600 | Multilabs: ~1.200 | Projection +7%; BPM focus. |
ColombiaStrong sector (4th in Latin America); 6% growth/year. Average pharmaceutical chemist: COP 3-6M/month (US$750-1,500). LHH: Scales by company size.
Again | Average Salary (COP/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 2.5M-5M | Lafrancol: ~3.5M; Pfizer: 4M | Production 7.74B COP; 52,400 jobs. |
2021 | 2.8M-5.5M | GSK: ~4.5M | +6% variation. |
2022 | 3M-6M | Local: 4M; Multinational: 5M | 2.6% manufacturing. |
2023 | 3.2M-6.5M | Procaps: ~5M | 21,000 direct. |
2024 | 3.5M-7M | Director: COP 7M+ (US$1,700); SMEs: 3M | LHH guide: +5%; large: +10%. |
ChileGrowth 4-6%/year; 0.73% GDP. Chemical average: CLP 1.2-2.2M/month (US$1,300-2,400).
Again | Average Salary (CLP/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 1M-1.8M | Megalabs: ~1.5M | Market US$1.514M. |
2021 | 1.1M-2M | Roemmers: ~1.7M | +51% imports. |
2022 | 1.2M-2.1M | Asilfa branches: 1.6M | 2% of chemical GDP. |
2023 | 1.3M-2.2M | Pfizer: ~2M | +14% interchangeable. |
2024 | 1.4M-2.3M | GSK: ~2.1M; Média 1.45M (US$1.550) | +70% availability; 45% women. |
PeruGrowth 4%; 93% in Lima. Average: PEN 2,000-5,000/month (US$530-1,320).
Again | Average Salary (PEN/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 1.800-3.500 | Incafarm: ~2,500 | USD 2B Market. |
2021 | 1.900-4.000 | Pharmacies: 3,000 | +20% generics. |
2022 | 2.000-4.500 | Pfizer: ~4.000 | 70% local coverage. |
2023 | 2.100-5.000 | Locations: 3,500 | USD 21M investment. |
2024 | 2.200-5.500 | Director: PEN 5,500 (US$1,450); Average 2,162 (US$570) | +4% projection; 30% mandatory generics. |
VenezuelaEconomic crisis; 14.6% growth in 2024, but low wages (~US$180 average). High inflation.
Again | Average Salary (USD/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020-2022 | 50-150 | Farmatodo: ~100; Locations: 80 | Production +35%; scarce. |
2023 | 100-200 | Crazy: ~150 | Low market; CIFAR: US$180 average. |
2024 | 150-250 | Multimax: ~200; Farmatodo: 300 (rumor) | +14.6%; US$4.38/unit. |
UruguayStable; farm subgroup with annual adjustments (e.g., +5.3% 2024). Average: UYU 40,000-60,000/month (US$1,000-1,500).
Again | Average Salary (UYU/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 30.000-50.000 | Megalabs: ~40.000 | +3% nominal. |
2021 | 35.000-55.000 | Locations: 45,000 | Hub regional. |
2022 | 38.000-58.000 | Pfizer: ~50.000 | 50% women. |
2023 | 40.000-60.000 | GSK: ~55.000 | Adjustment +2.2%. |
2024 | 42.000-65.000 | Roemmers: ~60.000; +5.3% jan | Projection +27.8%; RH base. |
ParaguayGrowth 60% (2019-2024); 45,000 jobs. Minimum wages ~Gs. 2.8M/month (US$370); average pharmacist Gs. 4-7M (US$530-930).
Again | Average Salary (Gs./month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 3M-5M | Locations: ~4M | 54% national market. |
2021 | 3.2M-5.5M | Pfizer: ~5M | +60% sales. |
2022 | 3.5M-6M | Importers: 4.5M | 3% GDP. |
2023 | 3.8M-6.5M | CIFARMA branches: 5.5M | 6,973 direct. |
2024 | 4M-7M | Multinationals: ~6M; +4.4% minimum (Gs. 2.84M, US$370) | 70% coverage; USD 1B revenue. |
North American Country Salary Survey (2020-2024)Focus on mid-level positions (pharmacist/scientist/analyst). Inflation-adjusted growth (e.g., +3-5% annually in Canada).
USARobust sector ($602B in 2023, +6% in 2024); 578,000 jobs. Average pharmacist: $119,000-$140,000/year. Scientists: $178,000-$190,000. Multinationals like Pfizer pay +25%.
Balance : Companies like Pfizer offer flexible PTO; avoid overload in R&D hubs like Boston.
Canada15% job growth (35k in manufacturing); total salaries US$2.4B in 2021. Pharmacist average: CAD 100k-107k/year (US$73k-78k). Quality: CAD 80k-120k.
Balance : Laws protect (40h/week); focus on hubs like Toronto/Montreal for flexibility.
GreenlandNon-existent sector (imports via Denmark); focus on public health. Overall average: DKK 279k/year (US$40k). Estimated pharma: DKK 37k/month (US$5.4k).
Balance : Low pressure; ideal for calm lifestyles but limited opportunities.
BermudaNo manufacturing; local pharmacies (e.g., People's Pharmacy). Average pharmacist: BMD 127k-131k/year (US$127k-131k). Small sector, focus on imports.
Balance : Small island favors work-life; but unstable supply chain (hurricanes).
USARobust sector ($602B in 2023, +6% in 2024); 578,000 jobs. Average pharmacist: $119,000-$140,000/year. Scientists: $178,000-$190,000. Multinationals like Pfizer pay +25%.
Again | Average Salary (US$/year) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 110.000-130.000 | Pfizer: ~125.000; J&J: 120.000 | COVID impact; +5% growth; sales reps ~US$150k total. |
2021 | 115.000-135.000 | GSK: ~130.000; Merck: 128.000 | Market US$576B; 37 FDA approvals. |
2022 | 120.000-140.000 | AbbVie: ~135,000; Biopharma medio: 157,000 | +6.7% for scientists; gender gap 22% (men US$194k median). |
2023 | 125.000-145.000 | Pfizer: ~140.000; Director: >230.000 | BLS: $139k average; +6.7% scientists ($190k). |
2024 | 130.000-150.000 | J&J: ~145,000; GSK: 142,000 | Projection US$639B; pharma median US$140k. |
Canada15% job growth (35k in manufacturing); total salaries US$2.4B in 2021. Pharmacist average: CAD 100k-107k/year (US$73k-78k). Quality: CAD 80k-120k.
Again | Average Salary (CAD/year) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 95.000-100.000 | Apotex: ~98,000; Pfizer Canada: 102,000 | Average hour CAD 29; pandemic impact. |
2021 | 97.000-102.000 | GSK: ~100.000; Sanofi: 105.000 | Total salaries +2.9%; 16k vacancies projected 2022-31. |
2022 | 99.000-104.000 | Merck: ~103.000; Retail: 99.749 | Glassdoor: CAD 104k average; +3% nominal. |
2023 | 101.000-106.000 | J&J: ~105.000; Quality Control: 110.000 | CAD 37-65 hour; Master's: up to CAD 211k. |
2024 | 103.000-108.000 | AstraZeneca: ~107,000; Pharmaceutical: 107,335 | Projection +2%; Toronto: CAD 98k. |
GreenlandNon-existent sector (imports via Denmark); focus on public health. Overall average: DKK 279k/year (US$40k). Estimated pharma: DKK 37k/month (US$5.4k).
Again | Average Salary (DKK/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020-2022 | 30.000-35.000 | Locations (e.g., government pharmacies): ~32,000 | Little data; economy dependent on fishing. |
2023 | 35.000-38.000 | Importers: 37,000 | Biotech media DKK 37,800; range 18,900-67,200. |
2024 | 36.000-39.000 | N/A (minimum sector) | Stable projection; Medical Advisor: DKK 54k. |
BermudaNo manufacturing; local pharmacies (e.g., People's Pharmacy). Average pharmacist: BMD 127k-131k/year (US$127k-131k). Small sector, focus on imports.
Again | Average Salary (BMD/year) | By Company (Examples) | Notes |
|---|---|---|---|
2020-2022 | 120.000-125.000 | People's Pharmacy: ~122.000; Locais: 120.000 | Imports; no granular data. |
2023 | 125.000-128.000 | EastPharma: ~126.000 | Range 1,060-3,110/month; median 1,850/month. |
2024 | 127.000-131.000 | GSK/Bermuda ops: ~130.000 | SalaryExpert: BMD 127k; hora US$61. |
European Countries Salary Survey (2020-2024)Focus on mid-level positions; growth adjusted for inflation.
GermanyLeading sector ($50B+ in 2023); 120k jobs. Average pharma: €4,000-6,000/month ($4,300-6,500). Multinationals like Bayer pay +25%.
Balance : Companies like Bayer offer 30 days PTO; avoid overload in R&D.
United Kingdom$40B market; 5%/year growth. Average: £3,000-4,500/month ($3,800-5,700).
Balance : NHS flexibility; health sector 5% of GDP.
France€50B sector; 100k jobs. Average: €3,500-5,000/month (US$3,800-5,400).
Balance : 35h/week; good for families.
ItalyMarket €40B; 70k jobs. Average: €2,500-4,000/month (US$2,700-4,300).
Balance : Stable sector; less pressure on SMEs.
RussiaMarket RUB 2.6T (US$28B); high inflation. Average: RUB 80,000-120,000/month (US$800-1,200).
Equilibrium : Unstable; migration common.
SpainUS$30B market; export +20%. Average: €2,800-4,200/month (US$3,000-4,500).
Balance : 40h/week; tourism balances.
PortugalMarket €3B; 10k jobs. Average: €1,500-2,500/month (US$1,600-2,700).
Balance : Low cost of living; good for young people.
TürkiyeMarket US$7B; 785 companies. Average: TRY 20,000-35,000/month (US$600-1,000, inflation adjusted).
Balance : High inflation; emerging sector.
NetherlandsUS$20B sector; high innovation. Average: €3,500-5,500/month (US$3,800-5,900).
Balance : 30% ruling tax for expats; 40h/week.
GermanyLeading sector ($50B+ in 2023); 120k jobs. Average pharma: €4,000-6,000/month ($4,300-6,500). Multinationals like Bayer pay +25%.
Again | Average Salary (€/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 3.500-5.000 | Bayer: ~4.500; Boehringer: 4.000 | Growth +5%; COVID impact. |
2021 | 3.700-5.300 | Merck: ~4.800 | +6% nominal; R&D focus. |
2022 | 3.900-5.600 | Pfizer Germany: ~5,000 | Inflation 7%; 11% R&D investment. |
2023 | 4.100-5.900 | GSK: ~5.200 | Average €61k/year manufacturing; +4%. |
2024 | 4.300-6.200 | J&J: ~5,500 | Projection +3%; pharmacist €80k/year. |
United Kingdom$40B market; 5%/year growth. Average: £3,000-4,500/month ($3,800-5,700).
Again | Average Salary (£/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 2.500-4.000 | GSK: ~3.500; AstraZeneca: 3.200 | +4%; pandemia boost. |
2021 | 2.700-4.200 | Pfizer UK: ~3.800 | £50k average pharmacist. |
2022 | 2.900-4.500 | Novartis: ~4,000 | Inflation 10%; +5%. |
2023 | 3.100-4.800 | Sanofi: ~4.200 | £50,853 pharmacist. |
2024 | 3.300-5.100 | Merck: ~4.500 | Projection +4%; £41k average pharma. |
France€50B sector; 100k jobs. Average: €3,500-5,000/month (US$3,800-5,400).
Again | Average Salary (€/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 3.000-4.500 | Sanofi: ~4.000 | +3%; manufacturing €54k/year. |
2021 | 3.200-4.700 | Servier: ~4,200 | R&D growth. |
2022 | 3.400-5.000 | Pfizer France: ~4,500 | Inflation 5%; Paris +10%. |
2023 | 3.600-5.200 | Novartis: ~4,800 | €48k pharmacist. |
2024 | 3.800-5.500 | Roche: ~5.000 | Projection +4%; biotech focus. |
ItalyMarket €40B; 70k jobs. Average: €2,500-4,000/month (US$2,700-4,300).
Again | Average Salary (€/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 2.200-3.500 | Churches: ~3,000 | +2%; production +10%. |
2021 | 2.300-3.700 | Angelini: ~3,200 | Export +15%. |
2022 | 2.400-3.900 | Recorded: ~3,500 | Inflation 8%; €52B production. |
2023 | 2.500-4.100 | Menarini: ~3,700 | €43k pharma technician. |
2024 | 2.600-4.300 | Zambon: ~3,900 | Projection +3%; generics 60%. |
RussiaMarket RUB 2.6T (US$28B); high inflation. Average: RUB 80,000-120,000/month (US$800-1,200).
Again | Average Salary (RUB/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 50.000-80.000 | Pharmstandard: ~60,000 | Pandemic +20%; US$16B market. |
2021 | 60.000-90.000 | R-Pharm: ~70.000 | Inflation 6%; import sub. |
2022 | 70.000-100.000 | Biocad: ~80.000 | Sanctions; +10% nominal. |
2023 | 80.000-110.000 | OTC Charge: ~90,000 | RUB 2.6T market; US$180 average. |
2024 | 90.000-130.000 | Veropharm: ~100,000 | +10%; inflation 7%. |
SpainUS$30B market; export +20%. Average: €2,800-4,200/month (US$3,000-4,500).
Again | Average Salary (€/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 2.500-3.800 | Grifols: ~3,200 | +3%; €2B total wages. |
2021 | 2.600-4.000 | Admiral: ~3,500 | Generics +15%. |
2022 | 2.700-4.200 | Farmaindustria: ~3.700 | Inflation 8%; €27.9B revenue. |
2023 | 2.800-4.400 | Was: ~3,900 | +4%; Barcelona +10%. |
2024 | 2.900-4.600 | Uriach: ~4.100 | Projection 5.4% CAGR. |
PortugalMarket €3B; 10k jobs. Average: €1,500-2,500/month (US$1,600-2,700).
Again | Average Salary (€/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 1.200-2.000 | Hovione: ~1,600 | +2%; export €106M. |
2021 | 1.300-2.100 | Regional: ~1,700 | +3%; 145 companies. |
2022 | 1.400-2.300 | Tecnimede: ~1.900 | Inflation 7%; pharmacist €20k/year. |
2023 | 1.500-2.400 | Bluepharma: ~2.000 | +4%; €1,497 average. |
2024 | 1.600-2.600 | Recipharm: ~2.100 | Projection +4%; minimum €820. |
TürkiyeMarket US$7B; 785 companies. Average: TRY 20,000-35,000/month (US$600-1,000, inflation adjusted).
Again | Average Salary (TRY/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 5.000-10.000 | Abdi Ibrahim: ~7,000 | Inflation 12%; US$450 assistant. |
2021 | 8.000-15.000 | Allergan: ~10.000 | +20%; export +10%. |
2022 | 12.000-22.000 | Deva: ~15.000 | Inflation 70%; TRY devaluation. |
2023 | 18.000-30.000 | Nobel: ~22.000 | US$5k average manufacturing. |
2024 | 25.000-40.000 | Santa Farma: ~30,000 | +50%; market US$2.1B. |
NetherlandsUS$20B sector; high innovation. Average: €3,500-5,500/month (US$3,800-5,900).
Again | Average Salary (€/month) | By Company (Examples) | Notes |
|---|---|---|---|
2020 | 3.000-4.500 | Janssen: ~4.000 | +4%; R&D focus. |
2021 | 3.200-4.800 | Organon: ~4,300 | €44k overall average. |
2022 | 3.400-5.100 | MSD: ~4.600 | Inflation 10%; biotech +15%. |
2023 | 3.600-5.300 | Philips Healthcare: ~4.800 | €69k specialist. |
2024 | 3.800-5.600 | Abbott: ~5.100 | Projection +5%; average €3,666. |
Set priorities early . A full-time salary of R$8,240 is great, but working 60 hours a week can burn you out. Choose companies with flexible policies, such as working from home, which are increasingly common in the industry.
Books aimed at Pharmaceutical Industry Propagandists and Representatives 
Consultants, Propagandists and Representatives Series
Negotiate your time . When taking on projects, align expectations with managers. Young people who deliver results in fewer hours—such as optimizing processes—earn respect and space for their personal lives.
Leverage technology . AI and task management tools reduce operational overhead. A pharmacist who uses these resources can focus on strategy, earning up to R$10,000 without pulling all-nighters.
Invest in well-being . Companies offer health plans and workplace fitness programs, but go further: take vacations and disconnect. Balanced young people maintain the energy to reach senior status (R$12,000) without breaking down.
Seek purpose in your work . Coordinating a sustainable project or a new medicine (initial R$7,500) aligns your career and values. For Millennials, this reduces the feeling of "selling your soul."
Shape your future . Before you turn 36, create a routine that sustains ambition and happiness. The pharmaceutical industry rewards those who work well, not those who work harder—find your balance now.
👉 Follow André Bernardes on Linkedin . Click here and contact me via WhatsApp.
Nenhum comentário:
Postar um comentário
Compartilhe sua opinião e ponto de vista: